Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Ischemic Heart Disease

  Free Subscription


13.04.2026

1 Am Heart J
4 Am J Cardiol
2 Am J Med
1 Am J Public Health
2 Angiology
3 Arterioscler Thromb Vasc Biol
2 Can J Cardiol
1 Chest
2 Circ Cardiovasc Imaging
1 Circ Cardiovasc Interv
1 Circ Genom Precis Med
1 Circ J
2 Circ Res
6 Circulation
1 Clin Cardiol
1 Crit Care Med
1 Heart
1 Hypertension
8 J Am Coll Cardiol
1 Lancet
1 Mayo Clin Proc
1 Mol Cell Biochem
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. HOES LLF, Geleijnse JM, Bemelmans RHH, Muller AF, et al
    An online, Predominantly Plant-based, Dietary Intervention for Improving Cardiovascular Risk: a Randomized Controlled Trial in People with Type 2 Diabetes.
    Am Heart J. 2026 Apr 2:107436. doi: 10.1016/j.ahj.2026.107436.
    PubMed         Abstract available


    Am J Cardiol

  2. COLE A, Ibrahim R, Weight N, Al-Jarshawi M, et al
    Utilization and Outcomes of Dual Antiplatelet Therapy in Patients with Active Cancer Presenting with Acute Myocardial Infarction: A Global Registry Study.
    Am J Cardiol. 2026 Apr 3:S0002-9149(26)00204.
    PubMed         Abstract available

  3. SIMEON MJ, Lee SK, Yee BF, Seto A, et al
    Associations Between Electrocardiographic Features and Type 1 and Type 2 Myocardial Infarction in Critically Ill Patients.
    Am J Cardiol. 2026 Apr 2:S0002-9149(26)00218.
    PubMed         Abstract available

  4. HOSSEINI K, Dastjerdi P, Sahzabi RY, Alipoor A, et al
    Mortality and Morbidity Benefit After Influenza Vaccination in High Cardiovascular Risk Population: a Systematic Review and Meta-analysis.
    Am J Cardiol. 2026 Apr 6:S0002-9149(26)00177.
    PubMed         Abstract available

  5. PANOULAS V, Schreiber T, Tsintzos S, Holy CE, et al
    Impella Protected Percutaneous Coronary Intervention Outcomes Compared with Intra-Aortic Balloon Pump: A Contemporary View.
    Am J Cardiol. 2026 Apr 2:S0002-9149(26)00203.
    PubMed         Abstract available


    Am J Med

  6. ZHU L, Gu TS, Zhang YK, Hu ST, et al
    Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction Following Acute Myocardial Infarction: A Multicenter Retrospective Cohort Analysis.
    Am J Med. 2026 Apr 7:S0002-9343(26)00272-X. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available

  7. JAVADI N, Jan MF, Tajik AJ
    Auricular Nodule in 53-Year-Old Man with Subclinical Coronary Artery Disease.
    Am J Med. 2026 Apr 2:S0002-9343(26)00268-8. doi: 10.1016/j.amjmed.2026.
    PubMed        


    Am J Public Health

  8. PLEASANTS H, Pike JR, Palta P, Bertoni AG, et al
    Psychosocial Risk and Resilience as Moderators of the Association Between Neighborhood Disadvantage and Incident Cardiovascular Disease Across Ethnoracial Groups: Multi-Ethnic Study of Atherosclerosis, United States, 2000-2019.
    Am J Public Health. 2026;116:711-721.
    PubMed         Abstract available


    Angiology

  9. YAN P, Yang X, Yang Z, Wang H, et al
    Association Between Carotid Plaque Characteristics and High-risk Coronary Plaque: A Virtual Histology Intravascular Ultrasound Study.
    Angiology. 2025 Apr 12:33197251333204. doi: 10.1177/00033197251333204.
    PubMed         Abstract available

  10. HADDAD TA, Toubasi AA, Fahmawi A, Zaid A, et al
    Clinical Outcomes of PCI in Hospitals With or Without Surgical Backup: A Meta-analysis.
    Angiology. 2026;77:554-562.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  11. RANA M, Wilcox UR, Nadkarni S
    Placenta Biology, Future Cardiovascular Health, and Impact on the Maternal-Fetal Heart.
    Arterioscler Thromb Vasc Biol. 2026 Apr 9. doi: 10.1161/ATVBAHA.125.323221.
    PubMed         Abstract available

  12. VAN SOLINGEN C, Muller M, Sowa MA, Barrett TJ, et al
    LUCAT1 Links Interferon Signaling in Platelets to Major Adverse Cardiovascular Events.
    Arterioscler Thromb Vasc Biol. 2026 Apr 9. doi: 10.1161/ATVBAHA.125.324358.
    PubMed        

  13. FANG Y, Zhang Z, Cao Q, Li Y, et al
    LL-37-ApoB-100 Complex Serves as a Biomarker of Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2026 Apr 9. doi: 10.1161/ATVBAHA.125.323486.
    PubMed         Abstract available


    Can J Cardiol

  14. RANGE G, Cayla G, Angoulvant D, Morelle JF, et al
    Impact of P2Y12 Inhibitors Pretreatment on Stent Thrombosis in Patients Undergoing Percutaneous Coronary Intervention: Insight France PCI Registry.
    Can J Cardiol. 2026;42:689-698.
    PubMed         Abstract available

  15. DOMA M, Ramadan A, Cogar B, McEntegart MB, et al
    Percutaneous Coronary Intervention for Chronic Total Occlusion in Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Can J Cardiol. 2026 Apr 6:S0828-282X(26)00297-7. doi: 10.1016/j.cjca.2026.
    PubMed        


    Chest

  16. GONZALEZ J, Yip R, Zhang J, Jirapatnakul A, et al
    Linking lungs and heart: centrilobular emphysema progression predicts coronary artery calcification progression during 18 years of follow-up.
    Chest. 2026 Mar 31:S0012-3692(26)00431-9. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  17. MAANIITTY T, Bar S, Bax JJ, Knuuti J, et al
    Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication.
    Circ Cardiovasc Imaging. 2026 Apr 6:e018840. doi: 10.1161/CIRCIMAGING.125.018840
    PubMed         Abstract available

  18. LIGA R, Neglia D
    Revascularization of Single-Vessel Coronary Artery Disease: Is it Still Worth Doing?
    Circ Cardiovasc Imaging. 2026 Apr 7:e019753. doi: 10.1161/CIRCIMAGING.126.019753
    PubMed        


    Circ Cardiovasc Interv

  19. SKALIDIS I, Cook S, Togni M
    Letter by Skalidis et al Regarding Article, "Angiography-Derived Fractional Flow Reserve During Percutaneous Coronary Intervention".
    Circ Cardiovasc Interv. 2026 Apr 9:e016774.
    PubMed        


    Circ Genom Precis Med

  20. XU J, Shi Z, Khetarpal SA, Mulford AJ, et al
    Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care Biobank.
    Circ Genom Precis Med. 2026 Apr 10:e005494. doi: 10.1161/CIRCGEN.125.005494.
    PubMed         Abstract available


    Circ J

  21. NAKAO S, Ishihara T, Tsujimura T, Hata Y, et al
    Prognostic Impact of Quantitative Flow Ratio-Derived Physiology for Intermediate Non-Infarct-Related Artery in Acute Myocardial Infarction.
    Circ J. 2026 Apr 9. doi: 10.1253/circj.CJ-25-1136.
    PubMed         Abstract available


    Circ Res

  22. RAPUSHI E, Aryal A, Yang T, Li Z, et al
    Mitochondria-Derived Vesicles and Mitochondrial Extracellular Vesicles in Health and Cardiovascular Disease.
    Circ Res. 2026;138:e327357.
    PubMed         Abstract available

  23. WANG Y, Tian R
    Intercellular Mitochondrial Transfer: Implications in Cardiovascular Health.
    Circ Res. 2026;138:e326986.
    PubMed         Abstract available


    Circulation

  24. KUYUCU I, Canavar OF, Dogruer RD, Altin AD, et al
    Correction to: Abstract 4367615: The Cardiovascular Paradox of Gout Prophylaxis: A Systematic Review and Meta-analysis.
    Circulation. 2026;153:e1116.
    PubMed        

  25. SCHRAMA TJ, Aengevaeren VL
    Disentangling the Relationship Between Exercise and Coronary Atherosclerosis: Wearable Training Data Are the Way Forward.
    Circulation. 2026;153:1023-1025.
    PubMed        

  26. LIU C, Li X
    Letter by Liu and Li Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1107-e1108.
    PubMed        

  27. STEPANIAN A, Jaffe IZ
    Response by Stepanian and Jaffe to Letters Regarding Article, "Ponatinib, but Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Inf
    Circulation. 2026;153:e1113-e1114.
    PubMed        

  28. ZHENG T, Yuan X, Liu H
    Letter by Zheng et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1109-e1110.
    PubMed        

  29. XU X, Zhang S, Bao L
    Letter by Xu et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1111-e1112.
    PubMed        


    Clin Cardiol

  30. NAVEED M, Saeed M, Saddique MS, Naveed M, et al
    Comment on "Epicardial Fat Thickness as a Marker of Coronary Artery Disease in Diabetics: A Single Center Study".
    Clin Cardiol. 2026;49:e70292.
    PubMed        


    Crit Care Med

  31. CHOTALIA M, Patel JM, Parekh D, Bangash MN, et al
    Future Directions in Characterizing Cardiovascular Dysfunction in Sepsis.
    Crit Care Med. 2026;54:1042-1043.
    PubMed        


    Heart

  32. MORRONE D, Sykes R, Berry C
    Myocardial infarction with non-obstructive coronary arteries: a pathway to achieve guideline adherence.
    Heart. 2026 Apr 6:heartjnl-2025-327727. doi: 10.1136/heartjnl-2025-327727.
    PubMed        


    Hypertension

  33. TSUR AM, Talmy T, Hershenson R, Fishman B, et al
    Adolescent Blood Pressure and Cardiovascular Disease Before Age 50 Years.
    Hypertension. 2026 Apr 7. doi: 10.1161/HYPERTENSIONAHA.125.26414.
    PubMed         Abstract available


    J Am Coll Cardiol

  34. EIJSVOGELS TMH, Kim JH, Aengevaeren VL, D'Ascenzi F, et al
    Masters Athletes With Abnormal Cardiovascular Findings: A Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESC and the American College of Cardiology.
    J Am Coll Cardiol. 2026 Apr 6:S0735-1097(26)05730.
    PubMed         Abstract available

  35. GEELS J, van Rhenen A, Gomes C, Dinmohamed AG, et al
    Cardiovascular Disease Risk in Adults With Hematological Malignancies: A Population-Based Cohort Study Using Linked Databases.
    J Am Coll Cardiol. 2026 Apr 1:S0735-1097(26)05557.
    PubMed         Abstract available

  36. ZHANG X, Acosta JN, Dogra S, Silva EN, et al
    Opportunistic Cardiovascular Risk Assessment Using Routine Head CT in the Emergency Department.
    J Am Coll Cardiol. 2026 Mar 31:S0735-1097(26)05563.
    PubMed         Abstract available

  37. JHA V, Modi GK
    Hidden CKD in Coronary Artery Disease: Albuminuria Testing in Routine CAD Care.
    J Am Coll Cardiol. 2026 Mar 13:S0735-1097(26)05564.
    PubMed        

  38. CHENG J, Chen J, He J
    Blood Pressure Control Trajectories and Cardiovascular Risk: Pathophysiological Variation or Implementation Gap?
    J Am Coll Cardiol. 2026 Apr 8:S0735-1097(26)00294.
    PubMed        

  39. WU S, Rhee JW, Armenian S
    Not All Hematologic Malignancies Are Created Equal: Charting Subtype-Specific Cardiovascular Risk.
    J Am Coll Cardiol. 2026 Mar 18:S0735-1097(26)05654.
    PubMed        

  40. WERNER GS, Kim JH, Hildick-Smith D, Kang DY, et al
    Quality of Life After Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Coronary Occlusions: EUROCTO and DECISION-CTO Meta-Analysis.
    J Am Coll Cardiol. 2026 Apr 8:S0735-1097(26)05598.
    PubMed         Abstract available

  41. PENG X, Song Q, Bai J, Liu Y, et al
    Blood Pressure Trajectories and Cardiovascular Outcomes in Older Patients: Insights From the STEP Trial.
    J Am Coll Cardiol. 2026 Apr 1:S0735-1097(26)05644.
    PubMed         Abstract available


    Lancet

  42. HOLCK EN, Holm NR, Hildick-Smith D, Lindsay MM, et al
    Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.
    Lancet. 2026;407:1374-1382.
    PubMed         Abstract available


    Mayo Clin Proc

  43. HAO QY, Zeng YH, Huang BS, Zhan ZB, et al
    Early-Life Cardiovascular Risk Factor Trajectories and Coronary Artery Calcium Progression in Midlife.
    Mayo Clin Proc. 2026 Apr 2:S0025-6196(26)18449.
    PubMed         Abstract available


    Mol Cell Biochem

  44. LUO L, Li L, Wu S, Zeng X, et al
    Mesenchymal stem cell exosomes alleviate ischemic myocardial injury by miR-125b-5p/BTG2 pathway.
    Mol Cell Biochem. 2026;481:1713-1725.
    PubMed         Abstract available


    PLoS One

  45. TURCHIN A, Shubina M, Morrison FJ, Ahmad NN, et al
    Cumulative excess weight exposure over time and cardiovascular risk: A prospective cohort study.
    PLoS One. 2026;21:e0344620.
    PubMed         Abstract available


  46. Expression of Concern: Demographics and regional trends of ischemic heart disease-related mortality in older adults in the United States, 1999-2020.
    PLoS One. 2026;21:e0346407.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum